However, in SOX11− MCL cells, the low levels of PRDX2 are not able to manage oxidative stress generated during chemotherapy, and eventually tumor cells die upon treatments due to the increased lethal levels of ROS in SOX11− MCLs cells. This evidence concerns the gene PRDX2 and neoplasm.